Pandemieplan für respiratorische Krankheiten

Pandemic Preparedness and Response Health Action Plan 2023
Austria English PDF
National

AI-Generated Document Summary

Objectives

Austria’s pandemic plan for respiratory diseases aims to strengthen national preparedness and enable an effective, flexible and proportionate response to pandemics caused by SARS-CoV-2, influenza and novel respiratory pathogens. It is structured around preparation and pandemic phases, treats the plan as a living document, and seeks the best possible protection of the population while adapting action to the epidemiological situation, pathogen characteristics, scientific evidence and wider social, psychosocial and economic effects.

  • Strengthen legal preparedness by reviewing and developing epidemic-control law in light of COVID-19 experience, scientific evidence, international standards, data protection and fundamental rights.
  • Develop robust information, reporting and surveillance capacity, including an enhanced Epidemiological Reporting System, standardised data flows, respiratory-disease surveillance, genomic sequencing and wastewater monitoring.
  • Maintain diagnostic, laboratory and testing readiness, with capacity to be rapidly expanded during a pandemic and sufficient diagnostic access for symptomatic people when a new pathogen emerges.
  • Secure medical countermeasures through advance procurement, strategic federal stockpiling, supply arrangements for medicines and vaccines, and preparation for large-scale testing and vaccination programmes.
  • Establish crisis-management, advisory and coordination arrangements that support epidemiological assessment, forecasting, evidence-informed decisions and implementation across federal, provincial, European and international levels.
  • Improve health literacy, risk communication and crisis communication through transparent, consistent, accessible, multilingual, evidence-based and audience-oriented information that also considers psychosocial needs.
  • Apply measures to reduce transmission and severe disease, including testing, tracing, isolation or movement restrictions, mask requirements, access rules, gathering controls, travel measures and closures where legally authorised, necessary and proportionate.
  • Balance anticipated public-health benefits against potential social, psychosocial and economic harms, keep measures practical and understandable, and reassess their appropriateness as circumstances and evidence change.
  • Evaluate preparedness continuously, conduct regular exercises, transfer learning from pandemic operations into subsequent preparedness, and revise arrangements when conditions, knowledge, standards or legal requirements change.

Implementation

Implementation combines federal strategic leadership with provincial operational delivery, supported by statutory powers, standing coordination bodies, expert advice, surveillance and scalable service structures. The Federal Ministry of Social Affairs, Health, Care and Consumer Protection has federal responsibility for communicable-disease oversight, while provincial governors and district administrative authorities generally implement surveillance and control through indirect federal administration under ministerial instructions and decrees.

  • Establish or activate a federal health-ministry crisis team during a pandemic, with defined responsibilities, authority, staffing, premises, information-technology equipment, model processes and links to national, regional and international crisis structures.
  • Use the Epidemics Act 1950 and associated regulations as core legal instruments, alongside relevant social-insurance, medicines and medical-devices legislation; employ recommendations, binding ministerial directives and regulations according to the legal basis and operational need.
  • Coordinate national action through the State Crisis and Disaster Management system, conferences of provincial health-directorate officials and health ministers, and federal ministry–province meetings on legal issues, procurement, distribution, hospital capacity, testing and vaccination.
  • Convene expert bodies, including the Supreme Sanitary Council, National Immunisation Panel, forecasting consortium, epidemiological risk-assessment commission and, where needed, a multidisciplinary pandemic advisory board covering health, social, psychosocial and economic impacts.
  • Engage the Austrian Agency for Health and Food Safety, Gesundheit Österreich GmbH, reference centres and scientific institutions in data collection, assessment, laboratory expertise and advice to the federal health ministry.
  • Coordinate internationally through World Health Organization and European Union mechanisms, including the Event Information Site, Early Warning and Response System, Health Security Committee, Health Emergency Preparedness and Response Authority Board, Health Crisis Board and Integrated Political Crisis Response mechanism.
  • Operate notification and surveillance systems that record notifiable cases, support case-based monitoring, trigger official measures such as isolation and contact tracing, and enable notification of relevant public-health events to the World Health Organization and European Union channels.
  • Compile an epidemiological situation picture using infections, deaths, hospitalisations, virus variants, population immunity and vaccination coverage, supplemented by forecasts, modelling, hospital-capacity data, testing data and workforce-absence information.
  • Prepare procurement responsibilities, storage and logistics jointly with other ministries and provinces, transform the COVID-19 stockpile into a strategic federal crisis stockpile with Defence Ministry cooperation, and distribute necessary medical supplies when required.
  • Assign national preparation of testing and vaccination structures to the federal health ministry while leaving organisation and delivery to the federal provinces; use inter-authority working groups to plan materials, workforce and premises.
  • Target testing according to defined objectives and priority groups, rather than assuming unlimited non-targeted public testing is appropriate; consider modelling, feasibility and substantial costs before broad testing is adopted.
  • Apply case and contact tracing rapidly when feasible, but simplify procedures and consider regulated movement restrictions when high case numbers make individually ordered isolation operationally ineffective.
  • Review restrictive interventions, including entry bans, curfews, educational closures and travel restrictions, through benefit-harm assessments and use them only where epidemiologically justified, with highly restrictive measures limited to the shortest feasible duration.

Financing is not quantified in the supplied material. The general constitutional principle is that each level of government bears the costs of its own functions, subject to statutory exceptions: section 36 of the Epidemics Act assigns specified pandemic-related costs to the federal government, and special legislation may provide further federal cost coverage.

Monitoring & Evaluation

Monitoring and evaluation are centred on comprehensive epidemiological surveillance, timely data integration, structured assessment of risk and regular revision of preparedness and response arrangements. The plan treats pandemic preparedness as a continuing cycle of surveillance, forecasting, exercises, learning and adaptation rather than a fixed set of instructions.

  • Maintain surveillance of respiratory diseases and pathogens to detect spread and health impacts early and to inform prevention, control and evaluation. This includes monitoring acute respiratory infection, influenza-like illness in primary care, severe acute respiratory infection in hospitals, genomic sequencing and wastewater.
  • Use the Epidemiological Reporting System to support notification, case-based monitoring and analysis of infection trends. Notifiable diseases, deaths and, for specified diseases, suspected cases are recorded in the register of notifiable diseases; notification can trigger isolation, environmental investigation and contact tracing.
  • Develop the Epidemiological Reporting System further with the federal provinces, standardise reporting channels, accelerate access to existing data and connect relevant regional and institutional information-technology systems.
  • Make relevant data available accurately and promptly, including hospital capacity and occupancy, intensive-care occupancy, deaths, testing, contact tracing and staff absences. Analyse anonymised or pseudonymised data, with data-protection safeguards, to assess the need for and effectiveness of measures and support processes such as contact tracing.
  • Compile an epidemiological situation picture using new infections, deaths, hospitalisations, dominant virus variants, population immunity and vaccination coverage, supported by electronic registers and regular surveys or investigations. The federal health ministry crisis staff has primary responsibility for presenting this assessment, with institutional and provincial support.
  • Produce regular forecasts of case development and pandemic-related hospitalisations, including medium- and longer-term modelling, and conduct regular epidemiological risk assessment through a dedicated commission.
  • Use national, European and international information-sharing mechanisms for early detection, surveillance and cross-border coordination. The federal health ministry acts as Austria’s contact point for the World Health Organization Event Information Site and the European Commission’s Early Warning and Response System, with operational support from the Austrian Agency for Health and Food Safety.
  • Notify the World Health Organization within 24 hours when a public-health event in Austria requires notification under the International Health Regulations; a corresponding European Union obligation also applies.
  • Evaluate preparedness measures continuously against changing conditions, international standards, experience, scientific evidence and legal developments, and amend the plan where needed.
  • Conduct regular exercises to test staff competence and crisis-structure readiness, and incorporate exercise findings into preparedness updates.
  • Monitor interventions continuously where their effects are uncertain, reassess benefit and harm when evidence changes, and review longer-term or highly restrictive measures at suitable intervals.
  • Publish selected expert outputs, including Corona Commission risk assessments and recommendations online and assessments and statements from the multidisciplinary GECKO advisory body in an Executive Report.

The supplied material does not provide a single consolidated indicator framework, quantified performance targets, routine reporting timetable, audit programme or independent accountability process for the plan as a whole.

Costing & Financing

Resource planning focuses on maintaining scalable public-health, laboratory, testing, vaccination, procurement and stockpiling capacities. The material provides legal principles for allocating some pandemic-related costs, but does not provide an overall budget, expenditure forecast, funding gap, resource-mobilisation target or economic assumptions for the pandemic plan.

  • Apply the general constitutional principle that the federal government and other territorial authorities bear costs arising from their own responsibilities unless legislation specifies otherwise.
  • Use the Epidemics Act 1950 provision that defines pandemic-related costs borne by the federal government, including specified costs initially incurred by the federal provinces.
  • Apply additional statutory arrangements where relevant, including the COVID-19 Special-Purpose Subsidy Act, which is identified as an example of federal assumption of pandemic-response costs.
  • Prepare procurement procedures, supply contracts, storage and logistics arrangements, and a strategic federal crisis stockpile to secure essential medical products. The existing COVID-19 stockpile is to be converted with the Federal Ministry of Defence, taking account of European recommendations.
  • Plan national testing and vaccination structures, while assigning organisation and delivery to the federal provinces and defining requirements for materials, staff and premises through inter-authority working groups.
  • Recognise that permanently retaining laboratory and testing capacity at full pandemic levels is not feasible for financial and organisational reasons. Prepare legal arrangements that could permit federal payment for examinations undertaken by private laboratories when necessary.
  • Consider substantial costs, expected epidemiological benefit and operational feasibility before pursuing broad, non-targeted public testing. The effectiveness of Austria’s extensive COVID-19 testing strategy was not established in the cited comparison, despite very substantial expenditure.
  • Provide medically relevant supplies, including medical equipment, protective equipment and disinfectants, through procurement and distribution arrangements that may draw on the strategic federal crisis warehouse. COVID-19 legislation enabled emergency stocks to be supplied without charge to Länder, federal bodies and social-insurance institutions.
  • Recognise that case and contact tracing during COVID-19 required substantial personnel and infrastructure resources and generated very high costs, yet could not be fully managed at high case numbers.
  • Take social, psychosocial and economic effects into account when assessing restrictive measures, including entry bans, curfews, school closures and travel restrictions, alongside their epidemiological benefits.

No monetary amounts, currency-denominated allocations, programme budgets, funding sources beyond the specified legal cost-allocation arrangements, or quantified financing gaps are included in the supplied extracts.

Document Viewer